Analysis of lymph node dissection in patients with ≥7-cm renal tumors
Carcinoma, Renal Cell
Lymph Node Excision
We did not find a difference in recurrence-free or overall survival in patients with ≥7-cm tumors whether or not they underwent LND. Node-positive disease was associated with worse outcomes, suggesting that LND provides important staging information that can be important in the design of adjuvant clinical trials.